These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12617185)

  • 1. A multi-center prospective randomized trial of buffy coat depleted- and leukocyte filtered erythrocyte transfusions in vascular- and gastrointestinal oncologic surgery.
    van Hilten JA; Brand A;
    Vox Sang; 2002 Aug; 83 Suppl 1():453-6. PubMed ID: 12617185
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery.
    Tartter PI; Mohandas K; Azar P; Endres J; Kaplan J; Spivack M
    Am J Surg; 1998 Nov; 176(5):462-6. PubMed ID: 9874434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting.
    Vamvakas EC
    Transfus Med Rev; 2002 Oct; 16(4):304-14. PubMed ID: 12415516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.
    Bilgin YM; van de Watering LM; Eijsman L; Versteegh MI; Brand R; van Oers MH; Brand A
    Circulation; 2004 Jun; 109(22):2755-60. PubMed ID: 15148271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion.
    van Prooijen HC; Aarts-Riemens MI; van Oostendorp WR; Hené RJ; Gmelig-Meyling FH; de Weger RA
    Br J Haematol; 1995 Sep; 91(1):219-23. PubMed ID: 7577637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery.
    van Hilten JA; van de Watering LM; van Bockel JH; van de Velde CJ; Kievit J; Brand R; van den Hout WB; Geelkerken RH; Roumen RM; Wesselink RM; Koopman-van Gemert AW; Koning J; Brand A
    BMJ; 2004 May; 328(7451):1281. PubMed ID: 15142885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-Trial.
    Meybohm P; Lindau S; Treskatsch S; Francis R; Spies C; Velten M; Wittmann M; Gueresir E; Stoppe C; Kowark A; Coburn M; Selleng S; Baschin M; Jenichen G; Meersch M; Ermert T; Zarbock A; Kranke P; Kredel M; Helf A; Laufenberg-Feldmann R; Ferner M; Wittenmeier E; Gürtler KH; Kienbaum P; de Abreu MG; Sander M; Bauer M; Seyfried T; Gruenewald M; Choorapoikayil S; Mueller MM; Seifried E; Brosteanu O; Bogatsch H; Hasenclever D; Zacharowski K;
    Trials; 2019 Feb; 20(1):101. PubMed ID: 30717805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis.
    Bilgin YM; van de Watering LM; Eijsman L; Versteegh MI; van Oers MH; Brand A
    Transfus Med; 2007 Aug; 17(4):304-11. PubMed ID: 17680957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells.
    Innerhofer P; Luz G; Spötl L; Hobisch-Hagen P; Schobersberger W; Fischer M; Nussbaumer W; Lochs A; Irschick E
    Transfusion; 1999 Oct; 39(10):1089-96. PubMed ID: 10532603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial.
    van de Watering L; Hermans J; Witvliet M; Versteegh M; Brand A
    Transfusion; 2003 Jun; 43(6):765-71. PubMed ID: 12757528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukoreduction vs buffy-coat depletion and the safety of blood transfusion.
    Wallis JP
    JAMA; 2003 Sep; 290(12):1580; author reply 1580. PubMed ID: 14506115
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis*.
    Curley GF; Shehata N; Mazer CD; Hare GM; Friedrich JO
    Crit Care Med; 2014 Dec; 42(12):2611-24. PubMed ID: 25167086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications.
    Bilgin YM; van de Watering LM; Versteegh MI; van Oers MH; Brand A
    Crit Care Med; 2010 Feb; 38(2):546-52. PubMed ID: 19864941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.
    van de Watering LM; Hermans J; Houbiers JG; van den Broek PJ; Bouter H; Boer F; Harvey MS; Huysmans HA; Brand A
    Circulation; 1998 Feb; 97(6):562-8. PubMed ID: 9494026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term survival rate of patients transfused with leucocyte-depleted and buffy-coat-poor blood during colorectal surgery--secondary publication. An eight-year post-trial follow-up study].
    Jensen LS; Puho E; Pedersen L; Mortensen FV; Sørensen HT
    Ugeskr Laeger; 2006 Jan; 168(5):481-4. PubMed ID: 16472439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.
    Weinreich SS; Remmerswaal EB; Laport R; van Rhenen DJ; Rombout-Sastrienkova E; Smit Sibinga CT; Vrielink H; Boog CJ
    Vox Sang; 2000; 79(2):83-6. PubMed ID: 11054045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer: a posttrial 15-year follow-up study.
    Mortensen FV; Jensen LS; Sørensen HT; Pedersen L
    Transfusion; 2011 Feb; 51(2):259-63. PubMed ID: 20804531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new cellulose acetate filter to remove leukocytes from buffy-coat-poor red cell concentrates.
    Pietersz RN; Dekker WJ; Reesink HW
    Vox Sang; 1989; 56(1):37-9. PubMed ID: 2916334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.